The Bottom Line
The Bottom Line
We share a mutual goal with our partners: moving the industry forward. That starts with supporting our partners and helping them raise their bottom line. Sharing perspectives and insights, together, we can move the industry forward.
DNA is the rawest — but highest potential — investment to differentiate the pork we produce. Working with partners opens opportunities for shared learnings to move the pace of business forward, faster.
The use of genomics is a key factor in Acuity’s genetic development programs. Learn more about how Acuity’s implementation of genomics leads to an increase in accuracy for targeted traits.
With Acuity’s approach to genetic verification through their Commercial Test Herd, there is an opportunity to gather that individual boar fertility data — outside of the baseline motility and morphology parameters. Learn more about how Acuity evaluates fertility when selecting the best sires for a production environment.
Ian’s background in the swine industry fueled his passion for swine genetics and led him to join the Maschhoffs in 2011. In his role with Acuity, he will be focused on creating a strong, healthy supply chain of the best genetics for each customer. Learn more about his point of view.
As genetic potential sets the ceiling for production output, ensuring predictable performance is crucial for commercial success and profitability. Acuity’s commercial test herd ensures that by validating and assessing genetic potential by utilizing pen by sire trails and rigorous testing and evaluation.
Our priority is to ensure accessible, viable genetics that move the industry forward. Learn more about how we use insights and partnerships to drive genetic progress.
Justin Fix has spent his career in swine production; each career move has grown his perspective on generating value. He brings his unique production vantage point to Acuity. With both the Acuity team and the Acuity genetic lines, Justin focuses on supporting producers to bring value to the swine industry. Learn more about his perspective.
Dr. Schwab joined the Maschhoff’s in 2012. In the last eight years, he has been part of the team challenged to build an entirely new genetic program, the foundation for Acuity. Learn more about Dr. Schwab.
I believe one of the biggest mistakes anyone can make is accepting the status quo. In 2003, we found an opportunity to challenge the standards of the genetics industry and redefine how genetics really drive commercial productivity and profitability. Learn more about Acuity’s origin.